IPG Photonics Corporation — Q1 2012 Form 10-Q
Reporting period: Three months ended March 31, 2012; filed May 7, 2012. IPG develops and manufactures fiber lasers, fiber amplifiers, diode lasers and related products for global customers, with materials processing as its largest application market. Financial figures below are in U.S. dollars; amounts are in millions unless stated otherwise.
Financial performance and position
| Metric | Q1 2012 | Q1 2011 / prior balance date | Change |
|---|---|---|---|
| Net sales | $123.2 | $100.0 | +23.2% |
| Gross profit / gross margin | $68.7 / 55.8% | $53.7 / 53.7% | Margin +2.1 percentage points |
| Operating income | $45.2 | $34.1 | +32.5% |
| Net income attributable to IPG | $29.9 | $23.1 | +29.7% |
| Reported earnings per share | Basic $0.63; diluted $0.61 | Basic $0.49; diluted $0.47 | Higher year over year |
| Net cash provided by operating activities | $27.0 | $10.2 | +$16.9 |
| Capital expenditures and intangible purchases | $13.8 | $9.6 | Higher investment |
| Cash and cash equivalents | $377.1 | $180.2 at Dec. 31, 2011 | +$196.8 |
| Short-term investments | $18.5 | $25.5 at Dec. 31, 2011 | -$7.0 |
| Total liabilities / debt components | $128.2 / $26.4 of borrowings | $118.4 / $24.4 of borrowings at Dec. 31, 2011 | Debt includes $9.7 revolving borrowings and $16.7 term debt |
Working capital excluding cash and short-term investments was $149.0 million, compared with $135.1 million at year-end. Unused credit lines and overdraft facilities were $47.8 million. Stockholders’ equity was $658.4 million. The company reported compliance with its debt covenants at quarter-end.
Changes versus the prior comparable period
- Materials-processing sales rose 19.4% to $103.2 million; other-application sales rose 47.5% to $20.0 million. Materials processing represented 83.8% of sales, versus 86.4% a year earlier.
- Management attributed sales growth mainly to higher sales of high- and medium-power lasers for cutting and welding, and increased sales of high-power lasers for advanced applications.
- Gross margin improved with higher advanced-application sales, manufacturing efficiencies and lower costs for internally manufactured components. Inventory valuation provisions increased to $1.9 million from $1.0 million.
- Research and development expense increased 24.6% to $7.1 million; general and administrative expense increased 21.8% to $9.9 million. Foreign-exchange losses rose to $1.3 million from $0.7 million.
- Cash from operations increased to $27.0 million. The quarter’s $171.7 million of financing cash flow was primarily driven by a follow-on offering that generated $168.3 million net of offering expenses; this materially increased cash and shares outstanding.
Outlook, risks and unusual items
- IPG expected approximately $60 million in capital expenditures during 2012, principally for construction and capacity expansion. It anticipated aggregate increases in sales and marketing and research and development spending as it supports growth and product development. No specific revenue or earnings guidance was disclosed.
- Management highlighted customer concentration, long and variable sales cycles, inventory requirements, fixed manufacturing costs, and dependence on continued product acceptance. The five largest customers accounted for 17% of Q1 sales.
- International operations expose the company to foreign-exchange risk; it reported no foreign-currency hedges outstanding at March 31, 2012. The filing identifies the euro, yen, ruble and yuan among relevant currencies.
- Other expense included approximately $1.1 million related primarily to final payments on contingent consideration from a prior acquisition. The company determined an additional $1.8 million final payment relating to a technology-company purchase.
- A patent lawsuit brought by IMRA America resulted in a jury verdict of no infringement in 2011. IMRA filed post-trial motions and retained appeal rights; IPG said it would contest them. No loss was considered probable and no amount was accrued at quarter-end.
- Rusnano’s 22.5% interest in IPG’s Russian subsidiary carries put rights exercisable from December 2015 to December 2017, subject to the disclosed terms; the redeemable noncontrolling interest was recorded at $48.4 million.
- Disclosure controls were assessed as effective, with no material change in internal control over financial reporting reported during the quarter.
Most important facts for investors to verify
- Reconcile the follow-on offering proceeds, share issuance and resulting dilution; the filing reports 50.97 million shares outstanding at March 31 and 50.98 million at May 3.
- Monitor whether revenue growth and margin improvement persist, especially across materials processing and advanced applications, and whether inventory provisions remain elevated.
- Track operating cash conversion, including receivables growth, the $60 million capital-spending expectation and the distinction between cash generated by operations and offering proceeds.
- Review the status and potential financial exposure of the IMRA litigation and the Russian subsidiary’s redeemable minority interest.
- Check debt maturity, covenant compliance and currency exposure, particularly if operating conditions or exchange rates change.